• 00Days
  • 00Hrs
  • 00Mins
  • 00Secs

Cepheid is dedicated to improving healthcare by pioneering molecular diagnostics that combine speed, accuracy, and flexibility. The company’s GeneXpert® systems and Xpert® tests automate highly complex and time-consuming manual procedures, providing A Better Way for institutions of any size to perform world-class PCR testing. Cepheid’s broad test portfolio spans respiratory infections, blood virology, women’s and sexual health, TB and emerging infectious diseases, healthcare-associated infectious diseases, oncology and human genetics. The company’s solutions deliver actionable results where they are needed most – from central laboratories and hospitals to near-patient settings. For more information, visit https://www.cepheid.com.

Share

Key dates

  • Abstract Submissions Open

    16 March

  • Early Bird Registrations Open

    24 April

  • Abstract Submissions Close

    1 July

  • Abstract Acceptance Notification

    Late August

  • Volunteer Applications Close

    26 August

  • Presenter Acceptance Deadline

    Early September

  • Early Bird Registration Deadline

    7 September

  • Presenter Registration Deadline

    Late September

  • Standard Registration Deadline

    6 November

Related